生命科学资讯

Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs

Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer

Bleecker's big bang: Formation Bio unveils new subsidiary with $605M Lynk deal

Sanofi, GSK ink preclinical pacts in quest for new autoimmune and cancer antibodies

Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans

Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial

Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025

Medline sets terms for massive $5.37B Nasdaq IPO

FDA qualifies 1st AI drug development tool for reading MASH images

Teleflex inks $2B in divestment deals for OEM, urology and acute care units

ASH: J&J makes case for Tecvayli combo as an alternative to CAR-T in 2nd-line multiple myeloma

ASH: Novartis details ianalumab's phase 3 win in rare blood disease

Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug

Ose narrows focus to conserve cash at expense of wider pipeline

ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma

Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech

FDA steers cancer CAR-T developers toward randomized superiority trials in policy shift

ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap

FDA clears Resmed AI for personalizing CPAP settings

With weight loss windfall, Lilly looks to become ‘backbone’ of global innovation: exec